Patient id (b)(4).This is filed for access site bleeding.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4+.Patient anatomy included a rotated heart, mitral annular calcification, thickened leaflets, bi-leaflet prolapse, thick and dense chords in the ventricle and a deep scallop between posterior 1/posterior 2.Visualization was difficult due to shadowing and the rotated heart.The clip delivery system (cds) was advanced into the patient anatomy and the anterior leaflet became caught on the grippers.Trouble shooting was performed; however, the clip (xtw) was unable to be freed.Additional troubleshooting was not performed, as the physician did not want to get the clip caught in the chordae.The clip was implanted at the same location where the anterior leaflet was caught.It was suspected that there was a small chordal tear and a new flail.A second clip (xt) was then implanted and the mr was reduced to grade 2-3+.Post procedure, minor bleeding was noted at the vessel access site.Manual pressure was applied, as well as a sand bag.Additionally, the patient experienced hypotension post procedure and a fluid bolus was administered.One day post procedure, the patient experienced supraventricular tachycardia (svt) and fever.No intervention was performed as treatment of the svt, but tylenol as administered for the fever.No infection was noted.The hypotension resolved on (b)(6) 2022.The svt and fever resolved on (b)(6) 2022.On (b)(6) 2022, an epinephrine/lidocaine subcutaneous injection was administered.The bleeding resolved on (b)(6) 2022.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of hemorrhage, as listed in the electronic g4 mitraclip system instructions for use (ifu), is a known possible complication associated with mitraclip procedures.The investigation was unable to determine a cause for the reported hemorrhage.The reported unexpected medical interventions and medication required were results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.Na.
|